Ruth S Shim1, Benjamin G Druss2, Shun Zhang3, Giyeon Kim4, Adesoji Oderinde5, Sosunmolu Shoyinka6, George Rust7. 1. National Center for Primary Care, Morehouse School of Medicine, Atlanta, GA, USA; Department of Psychiatry and Behavioral Sciences, Morehouse School of Medicine, Atlanta, GA, USA. Electronic address: rshim@msm.edu. 2. Rollins School of Public Health, Emory University, Atlanta, GA, USA. 3. National Center for Primary Care, Morehouse School of Medicine, Atlanta, GA, USA. 4. Center for Mental Health and Aging, The University of Alabama, Tuscaloosa, AL, USA; Department of Psychology, The University of Alabama, Tuscaloosa, AL, USA. 5. Department of Internal Medicine, Morehouse School of Medicine, USA. 6. Department of Psychiatry, University of Missouri School of Medicine, USA. 7. National Center for Primary Care, Morehouse School of Medicine, Atlanta, GA, USA; Department of Family Medicine, Morehouse School of Medicine, Atlanta, GA, USA.
Abstract
OBJECTIVE: Individuals with both physical and mental health problems may have elevated levels of emergency department (ED) service utilization either for index conditions or for associated comorbidities. This study examines the use of ED services by Medicaid beneficiaries with comorbid diabetes and schizophrenia, a dyad with particularly high levels of clinical complexity. METHODS: Retrospective cohort analysis of claims data for Medicaid beneficiaries with both schizophrenia and diabetes from fourteen Southern states was compared with patients with diabetes only, schizophrenia only, and patients with any diagnosis other than schizophrenia and diabetes. Key outcome variables for individuals with comorbid schizophrenia and diabetes were ED visits for diabetes, mental health-related conditions, and other causes. RESULTS: Medicaid patients with comorbid diabetes and schizophrenia had an average number of 7.5 ED visits per year, compared to the sample Medicaid population with neither diabetes nor schizophrenia (1.9 ED visits per year), diabetes only (4.7 ED visits per year), and schizophrenia only (5.3 ED visits per year). Greater numbers of comorbidities (over and above diabetes and schizophrenia) were associated with substantial increases in diabetes-related, mental health-related and all-cause ED visits. Most ED visits in all patients, but especially in patients with more comorbidities, were for causes other than diabetes or mental health-related conditions. CONCLUSION: Most ED utilization by individuals with diabetes and schizophrenia is for increasing numbers of comorbidities rather than the index conditions. Improving care in this population will require management of both index conditions as well as comorbid ones.
OBJECTIVE: Individuals with both physical and mental health problems may have elevated levels of emergency department (ED) service utilization either for index conditions or for associated comorbidities. This study examines the use of ED services by Medicaid beneficiaries with comorbid diabetes and schizophrenia, a dyad with particularly high levels of clinical complexity. METHODS: Retrospective cohort analysis of claims data for Medicaid beneficiaries with both schizophrenia and diabetes from fourteen Southern states was compared with patients with diabetes only, schizophrenia only, and patients with any diagnosis other than schizophrenia and diabetes. Key outcome variables for individuals with comorbid schizophrenia and diabetes were ED visits for diabetes, mental health-related conditions, and other causes. RESULTS: Medicaid patients with comorbid diabetes and schizophrenia had an average number of 7.5 ED visits per year, compared to the sample Medicaid population with neither diabetes nor schizophrenia (1.9 ED visits per year), diabetes only (4.7 ED visits per year), and schizophrenia only (5.3 ED visits per year). Greater numbers of comorbidities (over and above diabetes and schizophrenia) were associated with substantial increases in diabetes-related, mental health-related and all-cause ED visits. Most ED visits in all patients, but especially in patients with more comorbidities, were for causes other than diabetes or mental health-related conditions. CONCLUSION: Most ED utilization by individuals with diabetes and schizophrenia is for increasing numbers of comorbidities rather than the index conditions. Improving care in this population will require management of both index conditions as well as comorbid ones.
Authors: Ibrahim S Al-Zakwani; John J Barron; Michael F Bullano; Steve Arcona; Christopher J Drury; Tara R Cockerham Journal: Curr Med Res Opin Date: 2003 Impact factor: 2.580
Authors: Richard W Goldberg; Julie A Kreyenbuhl; Deborah R Medoff; Faith B Dickerson; Karen Wohlheiter; Li Juan Fang; Clayton H Brown; Lisa B Dixon Journal: Psychiatr Serv Date: 2007-04 Impact factor: 3.084
Authors: Naomi Launders; Kate Dotsikas; Louise Marston; Gabriele Price; David P J Osborn; Joseph F Hayes Journal: PLoS One Date: 2022-08-18 Impact factor: 3.752
Authors: David S Kroll; Karen Wrenn; John A Grimaldi; Lorna Campbell; Lisa Irwin; Maria Pires; Natalie Dattilo; Julia Schechter; Nomi Levy-Carrick; David F Gitlin Journal: Community Ment Health J Date: 2020-08-17
Authors: Andrea L Cherrington; Yulia Khodneva; Joshua S Richman; Susan J Andreae; Christopher Gamboa; Monika M Safford Journal: Diabetes Care Date: 2018-10-29 Impact factor: 19.112
Authors: Yu-Hsiang Kao; Michael D Celestin; Carl D Walker; Qingzhao Yu; John Couk; Sarah Moody-Thomas; Huijie Zhang; Tung-Sung Tseng Journal: Prev Chronic Dis Date: 2019-12-19 Impact factor: 2.830
Authors: Hayley D Germack; Khadejah Mahmoud; Mandy Cooper; Heather Vincent; Krista Koller; Grant R Martsolf Journal: BMC Health Serv Res Date: 2021-07-05 Impact factor: 2.655
Authors: William N Mkanta; Michelle C Reece; Abeer D Alamri; Emmanuel U Ezekekwu; Aishwarya Potluri; Neale R Chumbler Journal: Health Serv Res Manag Epidemiol Date: 2018-06-29